smooth muscle cell phenotype
Recently Published Documents


TOTAL DOCUMENTS

216
(FIVE YEARS 33)

H-INDEX

38
(FIVE YEARS 3)

Author(s):  
Elizabeth L. Chou ◽  
Christian L. Lino Cardenas ◽  
Mark Chaffin ◽  
Alessandro Arduini ◽  
Dejan Juric ◽  
...  

JCI Insight ◽  
2021 ◽  
Vol 6 (19) ◽  
Author(s):  
J. William Tierney ◽  
Brian C. Evans ◽  
Joyce Cheung-Flynn ◽  
Bo Wang ◽  
Juan M. Colazo ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Michelle Zurek ◽  
Einari Aavik ◽  
Rahul Mallick ◽  
Seppo Ylä-Herttuala

Atherosclerosis is a chronic inflammatory disease characterized by extensive remodeling of medium and large-sized arteries. Inward remodeling (=lumen shrinkage) of the vascular walls is the underlying cause for ischemia in target organs. Therefore, inward remodeling can be considered the predominant feature of atherosclerotic pathology. Outward remodeling (=lumen enlargement) is a physiological response compensating for lumen shrinkage caused by neointimal hyperplasia, but as a pathological response to changes in blood flow, outward remodeling leads to substantial arterial wall thinning. Thinned vascular walls are prone to rupture, and subsequent thrombus formation accounts for the majority of acute cardiovascular events. Pathological remodeling is driven by inflammatory cells which induce vascular smooth muscle cells to switch from quiescent to a proliferative and migratory phenotype. After decades of intensive research, the molecular mechanisms of arterial remodeling are starting to unfold. In this mini-review, we summarize the current knowledge of the epigenetic and transcriptional regulation of vascular smooth muscle cell phenotype switching from the contractile to the synthetic phenotype involved in arterial remodeling and discuss potential therapeutic options.


Biomaterials ◽  
2021 ◽  
Vol 273 ◽  
pp. 120810
Author(s):  
Deborah D. Chin ◽  
Christopher Poon ◽  
Jonathan Wang ◽  
Johan Joo ◽  
Victor Ong ◽  
...  

JCI Insight ◽  
2021 ◽  
Vol 6 (10) ◽  
Author(s):  
Manish Jain ◽  
Rishabh Dev ◽  
Prakash Doddapattar ◽  
Shigeyuki Kon ◽  
Nirav Dhanesha ◽  
...  

2021 ◽  
Vol 23 (5) ◽  
Author(s):  
Rachel M. Golonka ◽  
Johnathan Kawika Cooper ◽  
Rochell Issa ◽  
Pratyush Pavan Devarasetty ◽  
Veda Gokula ◽  
...  

Abstract Purpose of Review To review the current knowledge on interactions between dietary factors and microRNAs (miRNAs) in essential hypertension (EH) pathogenesis. Recent Findings There exists an integration of maintenance signals generated by genetic, epigenetic, immune, and environmental (e.g., dietary) factors that work to sustain balance in the gut-liver axis. It is well established that an imbalance in this complex, intertwined system substantially increases the risk for EH. As such, pertinent research has been taken to decipher how each signal operates in isolation and together in EH progression. Recent literature indicates that both macro- and micronutrients interrupt regulatory miRNA expressions and thus, alter multiple cellular processes that contribute to EH and its comorbidities. We highlight how carbohydrates, lipids, proteins, salt, and potassium modify miRNA signatures during EH. The disruption in miRNA expression can negatively impact communication systems such as over activating the renin-angiotensin-aldosterone system, modulating the vascular smooth muscle cell phenotype, and promoting angiogenesis to favor EH. We also delineate the prognostic value of miRNAs in EH and discuss the pros and cons of surgical vs dietary prophylactic approaches in EH prevention. Summary We propose that dietary-dependent perturbation of the miRNA profile is one mechanism within the gut-liver axis that dictates EH development.


Sign in / Sign up

Export Citation Format

Share Document